🇺🇸 Cefaclor Capsules in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Blood Pressure Decreased — 1 report (10%)
- Cardiac Arrest — 1 report (10%)
- Cellulitis — 1 report (10%)
- Condition Aggravated — 1 report (10%)
- Drug-Induced Liver Injury — 1 report (10%)
- Dyspnoea — 1 report (10%)
- Erythema — 1 report (10%)
- Exposure Via Breast Milk — 1 report (10%)
- Foetal Exposure During Pregnancy — 1 report (10%)
- Hyperhidrosis — 1 report (10%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Cefaclor Capsules approved in United States?
Cefaclor Capsules does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Cefaclor Capsules in United States?
Fundacion Clinic per a la Recerca Biomédica is the originator. The local marketing authorisation holder may differ — check the official source linked above.